PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported November 22, 2023

CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562

This recall is being issued due to items within the kit have expired prior to the overall kit expiration date listed on the insert.

Recall #
Z-0312-2024
Affected scope
1600 kits
Initiated
November 1, 2023
Verify with FDA Devices →
View my saved recalls

Medline Industries, LP - Northfield recalled CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562 - a moderate-severity action.

CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562 was recalled by Medline Industries, LP - Northfield in November 22, 2023. Reason: This recall is being issued due to items within the kit have expired prior to the overall kit expiration date…. Check the official notice for the remedy. Verify recall #Z-0312-2024 with the FDA Devices before acting.

The recall

Medline Industries, LP - Northfield issued this moderate-severity FDA Devices recall-This recall is being issued due to items within the kit have expired prior to the overall kit expiration date….

Moderate
severity level
Class II
classification
November 22, 2023
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0312-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562

Reason for recall

This recall is being issued due to items within the kit have expired prior to the overall kit expiration date listed on the insert.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-0312-2024
Date reported November 22, 2023
Date initiated November 1, 2023
Recalling firm Medline Industries, LP - Northfield
Firm location Northfield, IL
Affected scope 1600 kits
Distribution US Nationwide distribution in the state of California.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0312-2024) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562. Recalled by Medline Industries, LP - Northfield. Units affected: 1600 kits.
Why was this product recalled?
This recall is being issued due to items within the kit have expired prior to the overall kit expiration date listed on the insert.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 22, 2023. Severity: Moderate. Recall number: Z-0312-2024.
Where was the recalled product distributed?
Distribution: US Nationwide distribution in the state of California..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported November 22, 2023. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026